Does Dr. MONIQUE BENNETT FASBENDER have financial conflicts of interest?

Dr. MONIQUE BENNETT FASBENDER (O.D.) has received a total of $1,180 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,180 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MONIQUE BENNETT FASBENDER?

According to CMS Open Payments data, Dr. MONIQUE BENNETT FASBENDER received funding from ALCON VISION ($406), COOPERVISION ($332), and EYEVANCE PHARMACEUTICALS ($142).

Does Dr. MONIQUE BENNETT FASBENDER receive research grants or speaking fees?

Dr. MONIQUE BENNETT FASBENDER has received $1,180 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MONIQUE BENNETT FASBENDER

O.D.Real-Time Hydrated

Specialty: Optometrist

Practice Location: REEDSBURG, WI 53959

NPI Number: 1962808295

LIFETIME INDUSTRY VALUE

$1,180

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BENNETT FASBENDER is a verified Optometrist practitioner based in REEDSBURG, WI.

Between 2021 and 2025, Dr. BENNETT FASBENDER had an overall industry promotional and research financial footprint of $1,180 as recorded in the federal CMS Open Payments database.

$1,180 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BENNETT FASBENDER's primary funding source is ALCON VISION, which accounts for $406 (representing 34.4% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ALCON VISION

Rank 1

$406

34.4%

COOPERVISION

Rank 2

$332

28.1%

EYEVANCE PHARMACEUTICALS

Rank 3

$142

12%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.